DFCI: 16-237 Ph1b PVX-410 in SMM (Multiple Myeloma)
What is the Purpose of this Study?
Patients determined to be eligible, based on Screening assessments, will be enrolled in the study.
Who Can Participate in this Study?
Diagnosis of Smoldering Multiple Myeloma
What is Involved?
First, we will ask for a blood sample to determine eligibility.
If still eligible you will be asked to:
-Take the study drug as directed
-Complete blood draws
-Give a bone marrow sample
-A body scan (MRI, CT, X-ray)